Clinical Trial Update: Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated low-dose peginterferon-α2a for chronic hepatitis C genotypes 2 or 3 in HIV-coinfected patients; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Peginterferon alfa-2a (peginterferon alfa-2a)

Snippet

Sponsor: Sociedad Andaluza de Enfermedades Infecciosas | Conditions: Hepatitis C, Chronic, HIV Infections | Phase 4 | Status: COMPLETED